TATE — Tate & Lyle Income Statement
0.000.00%
- £2.35bn
- £2.31bn
- £1.65bn
- 83
- 52
- 29
- 56
Annual income statement for Tate & Lyle, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | Interim Report | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,882 | 1,211 | 1,375 | 1,751 | 1,647 |
Cost of Revenue | |||||
Gross Profit | 1,280 | 467 | 501 | 720 | 694 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,586 | 1,095 | 1,308 | 1,555 | 1,440 |
Operating Profit | 296 | 116 | 67 | 196 | 207 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 296 | 90 | 42 | 152 | 226 |
Provision for Income Taxes | |||||
Net Income After Taxes | 245 | 77 | 33 | 121 | 172 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 245 | 253 | 236 | 190 | 188 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 245 | 253 | 236 | 190 | 188 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.781 | 0.316 | 0.382 | 0.425 | 0.529 |
Dividends per Share | |||||
Special Dividends per Share |